Kyle O. Rove

ORCID: 0000-0002-2323-4139
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Enhanced Recovery After Surgery
  • Pediatric Urology and Nephrology Studies
  • Prostate Cancer Diagnosis and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Urological Disorders and Treatments
  • Kidney Stones and Urolithiasis Treatments
  • Anesthesia and Pain Management
  • Hormonal and reproductive studies
  • Urologic and reproductive health conditions
  • Hernia repair and management
  • Urinary Bladder and Prostate Research
  • Ureteral procedures and complications
  • Renal cell carcinoma treatment
  • Abdominal Surgery and Complications
  • Pediatric Pain Management Techniques
  • Urinary and Genital Oncology Studies
  • Pelvic floor disorders treatments
  • Bladder and Urothelial Cancer Treatments
  • Renal and related cancers
  • Porphyrin Metabolism and Disorders
  • Spinal Dysraphism and Malformations
  • Testicular diseases and treatments
  • Congenital gastrointestinal and neural anomalies
  • Cancer Treatment and Pharmacology

University of Colorado Anschutz Medical Campus
2013-2025

University of Colorado Denver
2012-2025

Children's Hospital Colorado
2018-2025

St. Louis Children's Hospital
2017-2019

Washington University in St. Louis
2017

University of Colorado Boulder
2015

Denver School of Nursing
2014

University of Colorado Health
2013

University of Colorado Hospital
2013

The Medical Center of Aurora
2011

The detection of prostate cancer relies primarily on abnormal digital rectal examination or increased serum specific antigen concentration. However, low positive predictive values result in many men with and/or suspicious having a negative biopsy. We investigated the value PCA3 (prostate gene 3) urine test predicting likelihood diagnosis before biopsy.We performed prospective, community based clinical trial to evaluate score any This was conducted at 50 urology practices United States....

10.1016/j.juro.2012.07.023 article EN The Journal of Urology 2012-09-19

Abstract BACKGROUND Extended transrectal ultrasound guided biopsies (TRUSB) of the prostate may not accurately convey true morphometric information and Gleason score (GS) cancer (PCa) clinical use template‐guided (5‐mm grid) transperineal mapping (TPMBs) remains controversial. METHODS We correlated clinical‐pathologic results 1,403 TPMB cores obtained from 25 men diagnosed with PCa 64 lesions found in their corresponding radical prostatectomy (RP) specimens. Special computer models...

10.1002/pros.22622 article EN The Prostate 2012-11-20

We determined the impact of a grid based, transperineal 3-dimensional mapping biopsy on decision making for primary management early stage prostate cancer.We prospectively performed 180 consecutive men who presented to our clinic between 2006 and 2009 with stage, organ confined cancer based transrectal ultrasound guided 10 12-core biopsy, 35 prior negative biopsies.At presentation median patient age was 60.5 years (range 43 77), specific antigen 4.8 ng/ml 0.5 72.4) volume cc 9 95). The...

10.1016/j.juro.2011.03.005 article EN The Journal of Urology 2011-05-22

Prostate cancer is the most commonly diagnosed cancer, with an estimated 240,000 new cases reported annually in United States. Due to early detection and advances therapies, more than 90% of patients will survive 10 years post diagnosis treatment. Radiation a treatment option often used treat localized disease; however, while radiation very effective at killing tumor cells, normal tissues are damaged as well. Potential side-effects due prostate cancer-related therapy include bowel...

10.1371/journal.pone.0044178 article EN cc-by PLoS ONE 2012-09-12

Study Type – Prognosis (inception cohort) Level of Evidence 1b What’s known on the subject? and What does study add? Large population screening trials like ERSPC, PCPT PLCO have noted that men with seemingly low PSA (even as 0.5 ng/dL) still can prostate cancer. Despite these findings, is predominantly used a current indicator for possible presence cancer rather than also serving prognostic marker. This examines larger number in diverse US to determine value man’s baseline or first PSA....

10.1111/j.1464-410x.2011.10224.x article EN BJU International 2011-06-28

Introduction Lower urinary tract reconstruction in paediatric urology represents a physiologically stressful event that is associated with high complication rates, including readmissions and emergency room visits. Enhanced recovery after surgery (ERAS) protocol set of multidisciplinary, perioperative strategies designed to expedite surgical without adversely impacting readmission or reoperation rates. Early data demonstrated ERAS reduced complications this population. Methods analysis In...

10.1136/bmjopen-2020-039035 article EN cc-by-nc BMJ Open 2020-11-01

Introduction Enhanced recovery after surgery (ERAS) is an evidence-based, multi-modal approach to decrease surgical stress, expedite recovery, and improve postoperative outcomes. ERAS increasingly being utilized in pediatric surgery. Its applicability patients undergoing abdominal tumor resections remains unknown. Methods Analysis A group of key stakeholders adopted principles developed a protocol suitable for the variable complexity solid resections. multi-center, prospective,...

10.3389/fsurg.2024.1393857 article EN cc-by Frontiers in Surgery 2024-05-22
Coming Soon ...